stars 1 stars 2 stars 3

JAFRAL is a leading CDMO specializing in bacteriophage-based products. With over a decade of experience, we develop a diverse range of bacteriophage products for human medicine, veterinary care, cosmetics, agriculture and food supplements, serving clients in over 40 countries worldwide. Beyond bacteriophages, JAFRAL manufactures high-quality biologics, including plasmid DNA, recombinant proteins, mRNA, outer membrane vesicles (OMVs), and live biotherapeutic products (LBPs). Our state-of-the-art facilities comply with GMP standards and are certified under GMP, ISO 14001 and EPA regulations, ensuring safety, efficiency and environmental responsibility. We provide end-to-end support across the lifecycle of biologics—from research and development to analytical process development, formulation studies, small- and large-scale production, preclinical and clinical manufacturing, and preparation of CMC documentation. Our comprehensive fill-and-finish services and tailored solutions meet the specific needs of every client. With long-standing international collaborations and extensive expertise, JAFRAL is a trusted partner for the development and manufacturing of biologic therapies. We combine flexibility, technical know-how and a commitment to quality to support clients at every stage—from concept to market.

JAFRAL Biosolutions Questions

The JAFRAL Biosolutions annual revenue was $6 million in 2026.

61 people are employed at JAFRAL Biosolutions.

JAFRAL Biosolutions is based in Ljubljana, Ljubljana.

The NAICS codes for JAFRAL Biosolutions are [621, 62, 6215, 62151].

The SIC codes for JAFRAL Biosolutions are [80, 807, 8071].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users